Physician profile
Brooke Colbert
NPI 1922295765
$1,496.21
in general payments reported to CMS, 2019-2025
10 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $138 · 2021: $233 · 2022: $278 · 2023: $180 · 2024: $275 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.25 |
| Education | $135.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $554.67 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals Lp | $464.66 | 2020-2025 | Breztri, Tezspire, Airsupra |
| Mylan Specialty L.P. | $198.23 | 2019-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.26 | 2021-2023 | Spiriva Respimat |
| Ethicon INC. | $74.70 | 2021 | |
| Tactile Systems Technology INC | $33.69 | 2025 | Nimbl, Flexitouch Plus |
| Amgen INC. | $27.46 | 2024-2025 | Tezspire |
| Sunovion Pharmaceuticals INC. | $18.31 | 2020 | |
| Genentech USA, INC. | $16.64 | 2022 | |
| Electromed, INC. | $15.59 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Colbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.